CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
Page 14 of 39 · 778 filings